The funding round was led by returning investors Verve Ventures and Zurich Kantonalbank. It also saw participation from 212 NexT Fund.
Haelixa also benefited from catalytic funding through the Temasek Trust Amplifier programme.
The firm’s proprietary DNA marker technology is designed to offer physical verification of product origin and authenticity.
The solution is intended to enhance traceability and support compliance for brands, addressing increasing regulatory scrutiny and industry concerns such as fraud, undeclared blending, and counterfeiting.
Currently, it is utilised in sectors including textiles, precious metals, and gemstones, and aligns with recognised standards such as GOTS and OEKO-TEX.
Gizem Yağız, managing partner at 212 NexT Fund, said: “Lack of transparency in supply chains today poses serious financial and reputational risks for brands. Haelixa’s DNA-based approach materially reduces this risk by scientifically verifying product origin and authenticity directly on the product itself. We are proud to join this founding round and support the team as they scale a new standard for traceability.”
Haelixa plans to use the funds to support selective team growth, broader product offerings, and increased collaboration with textile brands and supply-chain partners.
Haelixa CEO Patrick Strumpf said: “This investment enables us to scale globally as expectations for traceability continue to rise. It also allows us to expand into anti-counterfeiting, adding a strong new layer of value for luxury brands.”
Spun out of ETH Zurich, Haelixa has reached scaled commercial adoption, generating seven-figure revenue and securing multi-year agreements with major fashion and textile brands.
